Conivaptan + Rydapt Interaction
Moderateinteraction on record
Description
Strong CYP3A4 inhibitor that may increase midostaurin concentrations and risk of toxicity. Monitor for increased adverse reactions, especially during first week of administration.
Mechanism
CYP3A4 inhibition
Source: NLP:rydapt